Dr. Diana Gurevich Finkel, DO

Dr. Finkel practices at University Hospital in Newark, New Jersey, part of State of New Jersey.

Dr. Finkel's NPI, 1780704205, was assigned on March 29, 2007. Dr. Finkel graduated from Kansas City University of Medicine and Biosciences College of Osteopathic Medicine in 1997. Dr. Finkel holds New Jersey license 25MB07426000.

Dr. Finkel's primary practice is University Hospital, at 150 Bergen St, Newark, NJ 07103 in Essex County. The practice phone is (973) 972-4300.

Dr. Finkel's primary practice is University Hospital in Newark, New Jersey, part of State of New Jersey. The medical group on file is NJCRI Physician's Group. Dmand AI also links Dr. Finkel to 2 more group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Finkel practices, 3 sites in all. Vendor and product names are available with a free account.

Infectious disease is Dr. Finkel's primary specialty in the NPI Registry, under taxonomy code 207RI0200X. Dr. Finkel is board certified in infectious disease by the American Board of Internal Medicine. Dr. Finkel is licensed in New Jersey.

Dmand AI lists acute skin infection, hiv/aids, sepsis and UTI among the conditions Dr. Finkel treats.

CMS data shows 126 Medicare services from Dr. Finkel across 3 procedure codes in 2024, for 67 Medicare patients. Medicare paid $10,612 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 67 Medicare patients who saw Dr. Finkel in 2024. The largest group is under 65, with 25 patients. 75% of them have high blood pressure, and 69% have high cholesterol. 63% are also on Medicaid. Their average risk score is 3.21, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Finkel's median patient age at 41, with 42% women.

In 2024, Dr. Finkel wrote 2,387 Medicare Part D claims for 149 patients. 70% of them were for generic drugs. CMS names the drug for 1,899 of them, across 68 drugs with 11 or more claims each, at $1,973,463 in total drug cost. In 2023, CMS named 1,841 claims across 63 drugs.

Dr. Finkel accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Finkel as offering telehealth.

Dmand AI links 18 papers to Dr. Finkel, published from 2005 to 2025. 2023 was the busiest year, with 3. The most frequent topics are HIV Infections, HIV-1 and Intensive Care Units. Dr. Finkel has published most often in IDCases. Dr. Finkel's most frequent co-authors are Eli Samuel Goshorn, MD, Ambarish Mukund Athavale, MD and Sarah Bentil-Owusu, MD.

Dmand AI links Dr. Finkel to 6 clinical trials, 2 of them phase 2 studies. 2 are still active or recruiting. Conditions studied include Hepadnaviridae Infections, HIV Infections and Severe Acute Respiratory Syndrome. National Institute of Allergy and Infectious Diseases (NIAID) sponsors the most, 2.

CMS Open Payments shows 421 general payments to Dr. Finkel from 24 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 55% of the total. Gilead Sciences, Inc. paid the most, $5,565.

Dmand AI lists 3 awards for Dr. Finkel, most recently New Jersey Choice Top Doctor in 2017.

Dr. Finkel graduated from Kansas City University of Medicine and Biosciences College of Osteopathic Medicine in 1997. Dr. Finkel is a member of AAIM, IDSA and WPATH.

Dr. Finkel is in network with 16 carriers, including Elevance, Aetna and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.